Isophthalic Acid

Isophthalic Acid

SCHEMBL69359

Cl.O=C(O)c1cccc(C(=O)O)c1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Isophthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.68
CA12 O43570 1/20 0.68
CA1 P00915 1/20 0.68
CA6 P23280 1/20 0.68
CA9 Q16790 1/20 0.68
TSHR P16473 2/20 0.63
DAO P14920 1/20 0.63
NAPRT Q6XQN6 1/20 0.63
KMO O15229 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2C9 P11712 1/20 0.62
HPGD P15428 1/20 0.62
HSD17B10 Q99714 1/20 0.62
UNG P13051 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.59
ATM Q13315 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
FOLH1 Q04609 1/20 0.58
AKR1C3 P42330 1/20 0.58
TP53 P04637 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isophthalic Acid SCHEMBL377398 1.00 CA12 (0.68) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL9241794 1.00 CA12 (0.68) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL8084576 1.00 CA12 (0.68) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL5522892 1.00 CA12 (0.68) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL22462 0.97 CA12 (0.71) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL20500514 0.97 CA12 (0.71) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL28462260 0.97 CA12 (0.71) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL2512374 0.97 CA12 (0.71) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL147366 0.97 CA12 (0.71) CA12CA1CA2CA6CA9
Isophthalic Acid SCHEMBL28756611 0.97 CA12 (0.71) CA12CA1CA2CA6CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011941-A Multi-layer cross-linked impact-resistant wear-resistant organic silicon and preparation method and application thereof 杭州伽源科技有限公司 2026-05-12 CN claimed
EP-4722284-A1 LOW MELTING CARBOXAMIDE HALS FOR IMPROVED STABILIZATION OF POLYMERS OR RESINS CLARIANT INTERNATIONAL LTD (CH) 2026-04-08 EP claimed
US-20260054227-A1 COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME H2MO TECH PTE LTD (SG) 2026-02-26 US claimed
US-12485388-B2 Composite membrane and method of making the same H2MO TECHNOLOGY PTE LTD (SG) 2025-12-02 US claimed
CN-120005190-A Polyamide-imide resin, polyamide-imide resin film, and process for producing the same 中化学科学技术研究有限公司 2025-05-16 CN claimed
CN-120005191-A Polyamide-imide resin and process for producing polyamide-imide resin film 中化学科学技术研究有限公司 2025-05-16 CN claimed
CN-119231091-A Non-porous separator and lithium battery 安徽利科新材料科技有限公司 2024-12-31 CN claimed
US-20230330604-A1 MOLECULARLY POROUS CROSS-LINKED MEMBRANES UNIV KING ABDULLAH SCI & TECH (SA) 2023-10-19 US claimed
US-20230132994-A1 A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME H2MO TECHNOLOGY PTE LTD (SG) 2023-05-04 US claimed
EP-4126313-A1 A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME Nanyang Technological University (SG) 2023-02-08 EP claimed
EP-1020218-A1 COMPOSITE REVERSE OSMOSIS MEMBRANE AND PROCESS FOR PREPARING THE SAME NITTO DENKO CORPORATION (JP) 2000-07-19 EP claimed
EP-0459395-B1 Positive photo-sensitive resin composition SUMITOMO BAKELITE CO (JP) 1999-08-18 EP claimed
US-5449584-A Positive photo-sensitive resin composition comprising a photosensitive polybenzoxazole or a mixture of a polybenzoxazole, an organic solvent soluble polymer and a diazoquinone and/or a dihydropyridine compound SUMITOMO BAKELITE COMPANY, LTD. (JP) 1995-09-12 US claimed
EP-0459395-A2 Positive photo-sensitive resin composition SUMITOMO BAKELITE COMPANY LIMITED (JP) 1991-12-04 EP claimed
EP-0227043-A2 Composite semipermeable membrane and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-07-01 EP claimed
US-4659475-A SEPARATION; DESALINIZATION MIDWEST RESEARCH INSTITUTE (US) 1987-04-21 US claimed
US-4469850-A BLEND OF AROMATIC POLYCARBONATE AND COPOLYESTERCARBONATE GENERAL ELECTRIC COMPANY (US) 1984-09-04 US claimed
US-4401803-A Process for the preparation of aromatic polyesters ISOVOLTA OSTERREICHE ISOLIERSTOFFWERK AKTIENGESELLSCHAFT (AT) 1983-08-30 US claimed
US-4311822-A Interfacial production of poly(ester carbonate) or polyester including acid chloride synthesis ALLIED CORPORATION (US) 1982-01-19 US claimed
EP-0040315-A1 Interfacial production of poly(ester carbonate) or polyester including acid chloride synthesis ALLIED CORPORATION (US) 1981-11-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260054227-A1 COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME AQP1, AQP4, AQP3 CA2 1281/4885CA12 821/4885CA1 1102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.